Connect Biopharma Holdings Limited Ordinary Shares

CNTB XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

130M

Short interest (Jul 15)

3.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

1.11%

↓ 15.2%

Available Shares

↑ 11.3%

Price Chart

Company Overview

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001835268

Asset Type: CS

Market Data

Market Cap: $134,742,645

Employees: 64

Status: Active

Short Interest

Current Borrow Fee 1.11%

Range: 1.11% - 1.34%

Available Shares 1M

Range: 750K - 1M

Recent Changes

Fee Change: ↑ 48.1%

Available Change: ↑ 37.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime